Literature DB >> 28194512

Should all patients with sepsis receive anticoagulation? Yes.

Ferhat Meziani1,2, Satoshi Gando3, Jean-Louis Vincent4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28194512     DOI： 10.1007/s00134-016-4621-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

Review 1.  What's new in the diagnostic criteria of disseminated intravascular coagulation?

Authors:  Satoshi Gando; Ferhat Meziani; Marcel Levi
Journal:  Intensive Care Med       Date:  2016-02-08       Impact factor: 17.440

2.  Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality.

Authors:  M Levi
Journal:  J Thromb Haemost       Date:  2015-02-20       Impact factor: 5.824

3.  Early Detection of Disseminated Intravascular Coagulation During Septic Shock: A Multicenter Prospective Study.

Authors:  Xavier Delabranche; Jean-Pierre Quenot; Thierry Lavigne; Emmanuelle Mercier; Bruno François; François Severac; Lélia Grunebaum; Madah Mehdi; Fatiha Zobairi; Florence Toti; Ferhat Meziani; Julie Boisramé-Helms
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

4.  Drotrecogin alfa (activated) in adults with septic shock.

Authors:  V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Simon Finfer; Bengt Gårdlund; John C Marshall; Andrew Rhodes; Antonio Artigas; Didier Payen; Jyrki Tenhunen; Hussein R Al-Khalidi; Vivian Thompson; Jonathan Janes; William L Macias; Burkhard Vangerow; Mark D Williams
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

5.  Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.

Authors:  J-F Dhainaut; S B Yan; D E Joyce; V Pettilä; B Basson; J T Brandt; D P Sundin; M Levi
Journal:  J Thromb Haemost       Date:  2004-11       Impact factor: 5.824

Review 6.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

7.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

Authors:  Edward Abraham; Konrad Reinhart; Steven Opal; Ignace Demeyer; Christopher Doig; Angel López Rodriguez; Richard Beale; Petr Svoboda; Pierre Francois Laterre; Stuart Simon; Bruce Light; Herbert Spapen; Judy Stone; Allan Seibert; Claus Peckelsen; Cathy De Deyne; Russell Postier; Ville Pettilä; Charles L Sprung; Antonio Artigas; Sandra R Percell; Vincent Shu; Christian Zwingelstein; Jeffrey Tobias; Lona Poole; James C Stolzenbach; Abla A Creasey
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

Review 8.  Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials.

Authors:  Y Umemura; K Yamakawa; H Ogura; H Yuhara; S Fujimi
Journal:  J Thromb Haemost       Date:  2016-02-01       Impact factor: 5.824

Review 9.  Coagulation inhibitor substitution during sepsis.

Authors:  F Fourrier; M Jourdain; A Tournois; C Caron; J Goudemand; C Chopin
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

10.  Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity.

Authors:  Toshiaki Iba; Marcello Di Nisio; Jecko Thachil; Hideo Wada; Hidesaku Asakura; Koichi Sato; Naoya Kitamura; Daizoh Saitoh
Journal:  Crit Care       Date:  2016-09-14       Impact factor: 9.097
View more
  8 in total

1.  Focus on sepsis: new concepts and findings in sepsis care.

Authors:  Jean-Francois Timsit; Etienne Ruppe; Ricard Ferrer
Journal:  Intensive Care Med       Date:  2018-10-10       Impact factor: 17.440

2.  Thrombomodulin favors leukocyte microvesicle fibrinolytic activity, reduces NETosis and prevents septic shock-induced coagulopathy in rats.

Authors:  Julie Helms; Raphaël Clere-Jehl; Elsa Bianchini; Pierrick Le Borgne; Mélanie Burban; Fatiha Zobairi; Jean-Luc Diehl; Lelia Grunebaum; Florence Toti; Ferhat Meziani; Delphine Borgel
Journal:  Ann Intensive Care       Date:  2017-12-08       Impact factor: 6.925

3.  The application of anticoagulant therapy to sepsis.

Authors:  Jecko Thachil; Toshiaki Iba
Journal:  J Intensive Care       Date:  2017-05-30

4.  Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection.

Authors:  Zhipeng Xu; Baoli Cheng; Shuiqiao Fu; Xu Liu; Guohao Xie; Zhongwang Li; Yun Ji; Qinghui Fu; Zhinan Xu; Xiangming Fang
Journal:  Infect Drug Resist       Date:  2019-09-04       Impact factor: 4.003

5.  Clinical Characteristics of Venous Thrombosis Associated with Peripherally Inserted Central Venous Catheter in Premature Infants.

Authors:  Weiwei Zhu; Hua Zhang; Yan Xing
Journal:  Children (Basel)       Date:  2022-07-28

Review 6.  Immunohaemostasis: a new view on haemostasis during sepsis.

Authors:  Xavier Delabranche; Julie Helms; Ferhat Meziani
Journal:  Ann Intensive Care       Date:  2017-12-02       Impact factor: 6.925

7.  Expert consensus on the diagnosis and treatment of thrombocytopenia in adult critical care patients in China.

Authors:  Jing-Chun Song; Shu-Yuan Liu; Feng Zhu; Ai-Qing Wen; Lin-Hao Ma; Wei-Qin Li; Jun Wu
Journal:  Mil Med Res       Date:  2020-04-03

8.  Global hemostatic status in patients with acute-on-chronic liver failure and septics without underlying liver disease.

Authors:  Ton Lisman; Bethlehem Arefaine; Jelle Adelmeijer; Ane Zamalloa; Eleanor Corcoran; John G Smith; William Bernal; Vishal C Patel
Journal:  J Thromb Haemost       Date:  2020-11-29       Impact factor: 5.824
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.